| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.094 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.003 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.095 | 0.004 |